PATLY.AIApplication
17200719 · USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS
Filed 2021-03-12 · Granted · Patent 12042481 (2024-07-23) The official file ↗The patent and its PDF ↗ · Art unit 1629 · Examiner Raymond J Henley III Easy · CPC A61K 31/403 · OTSUKA AMERICA PHARMACEUTICAL, INC. · MARSHALL, GERSTEIN & BORUN LLP
Office actions
1
first was Restriction requirement
RCEs
0
no appeal
To first action
24.4 mo
to disposition 40.4 mo
Statutes raised
103
1 actions read